BioCentury
ARTICLE | Clinical News

Niraparib: Phase III data

July 11, 2016 7:00 AM UTC

Top-line data from the double-blind, international Phase III NOVA trial in about 597 platinum-sensitive ovarian cancer patients who received >=2 prior platinum chemotherapy lines showed that once-dail...